查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1876805

家庭輸液治療市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Home Infusion Therapy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球家庭輸液治療市場價值為 366 億美元，預計到 2034 年將以 9.2% 的複合年成長率成長至 898 億美元。

家庭輸液治療市場 - IMG1

市場擴張的促進因素包括慢性病盛行率的上升、對經濟高效醫療解決方案的需求、輸液技術的進步以及老年人口的成長。家庭輸液療法是指在患者家中，透過靜脈注射 (IV) 或皮下注射的方式，將藥物或營養物質直接輸送到患者的血液中。這種療法通常用於長期使用抗生素、化療藥物、疼痛管理和腸外營養。癌症、糖尿病、胃腸道疾病、免疫缺陷和心臟衰竭等慢性病發病率的不斷上升是推動市場需求成長的主要因素。居家輸液療法使患者能夠在醫院外接受持續、安全的治療，從而減輕醫療系統的壓力，同時提高患者的便利性和舒適度。攜帶式輸液幫浦、智慧型設備和遠端監控系統的引入，進一步確保了安全性、精確的劑量控制以及患者與醫護人員之間的即時溝通，從而推動了家庭輸液療法的廣泛應用。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 366億美元
預測值 898億美元
複合年成長率 9.2%

由於輸液幫浦在慢性病管理和居家照護中發揮著至關重要的作用，預計到2024年，輸液幫浦市場佔有率將達到52.7%。這些設備能夠對疼痛管理、荷爾蒙治療和心臟藥物等療法進行可編程且精確的給藥，從而降低輸液不足或過量的風險。其精準性和可靠性使其成為確保居家治療安全的關鍵。

2024年，直銷通路的市佔率達到71.1%，預計到2034年將達到627億美元。這種模式使製造商能夠透過消除中間商利潤來提供更具競爭力的價格。大量採購優惠和長期協議吸引了尋求成本效益的醫療機構，從而促進了輸液泵、靜脈輸液套裝及相關耗材的普及。

2024年，北美家庭輸液治療市佔率達44.2%。該地區慢性疾病（如癌症、糖尿病、克隆氏症和免疫缺陷）的高發生率推動了對長期靜脈輸液治療的強勁需求。美國和加拿大不斷成長的患者群體也支撐著家庭輸液治療服務的穩定發展。

全球家庭輸液治療市場的主要參與者包括ICU Medical、Terumo、Fresenius Kabi、Moog、Mindray、B. Braun、Baxter、Nipro、JMS、Avanos（Halyard Health）、Contec Medical Systems、Polymed、Erenler Medikal、AMSINO和Becton Dickinson and Company。這些公司採用多種策略來鞏固其市場地位。他們專注於持續創新，開發攜帶式、方便用戶使用的輸液泵，並配備先進的安全技術和遠端監控功能。與醫院、診所和家庭醫療保健服務提供者建立策略合作夥伴關係，可以拓展分銷網路並提升信譽度。向新興市場進行地理擴張，有助於接觸新的患者群體，而併購則有助於整合技術和產品組合。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
  • 產業影響因素
    • 成長促進因素
      • 醫院感染病例不斷增加
      • 慢性病盛行率上升
      • 技術進步
      • 老年人口不斷增加
      • 人們對居家醫療保健解決方案的偏好日益增強
    • 產業陷阱與挑戰
      • 缺乏報銷
      • 家用輸液設備的安全隱憂與故障風險
    • 市場機遇
      • 靜脈注射免疫球蛋白（IVIG）療法的應用日益增多
      • 對個人化照護的需求日益成長
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術格局
    • 當前技術趨勢
    • 新興技術
  • 報銷方案
  • 家庭輸液治療產業的趨勢
  • 2024年定價分析
  • 家庭輸液治療產業的未來前景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 創業場景
  • 消費者行為分析
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
  • 競爭定位矩陣
  • 主要市場參與者的競爭分析
  • 關鍵進展
    • 併購
    • 合作夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章：市場估算與預測：依產品分類，2021-2034年

  • 主要趨勢
  • 點滴幫浦
    • 注射器
    • 體積
    • 門診
    • 胰島素
    • 其他輸液泵
  • 無針頭連接器
  • 靜脈輸液裝置
  • 靜脈導管

第6章：市場估算與預測：依應用領域分類，2021-2034年

  • 主要趨勢
  • 抗感染
  • 腸內營養
  • 特種藥品
  • 腸外營養
  • 水合
  • 化療
  • 其他應用

第7章：市場估計與預測：依配銷通路分類，2021-2034年

  • 主要趨勢
  • 直銷
  • 間接銷售

第8章：市場估算與預測：依地區分類，2021-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • AMSINO
  • B. BRAUN
  • Baxter
  • Becton Dickinson and Company
  • Contec Medical Systems
  • ERENLER MEDIKAL
  • FRESENIUS KABI
  • Halyard Health (AVANOS)
  • ICU Medical
  • JMS
  • Mindray
  • Moog
  • NIPRO
  • POLYMED
  • TERUMO
簡介目錄
Product Code: 435

The Global Home Infusion Therapy Market was valued at USD 36.6 billion in 2024 and is estimated to grow at a CAGR of 9.2% to reach USD 89.8 billion by 2034.

Home Infusion Therapy Market - IMG1

Market expansion is driven by the rising prevalence of chronic diseases, the shift toward cost-effective healthcare solutions, advancements in infusion technologies, and the growing elderly population. Home infusion therapy involves delivering drugs or nutrients directly into a patient's bloodstream via intravenous (IV) or subcutaneous methods in a home setting. This therapy is commonly applied for antibiotics, chemotherapy, pain management, and parenteral nutrition over prolonged periods. The increasing incidence of chronic conditions such as cancer, diabetes, gastrointestinal disorders, immune deficiencies, and heart failure is a major factor boosting demand. Home infusion therapy allows patients to receive continuous and safe treatment outside hospital facilities, reducing pressure on healthcare systems while enhancing convenience and comfort. The introduction of portable infusion pumps, smart devices, and remote monitoring systems further ensures safety, precise dosing, and real-time communication between patients and healthcare providers, driving broader adoption.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$36.6 Billion
Forecast Value$89.8 Billion
CAGR9.2%

The infusion pumps segment accounted for 52.7% share in 2024 owing to their essential role in chronic disease management and home care. These devices provide programmable and accurate dosing for therapies such as pain management, hormone treatments, and cardiac medications, reducing the risk of under- or over-infusion. Their precision and reliability make them critical for ensuring safe therapy in home settings.

The direct sales captured a share of 71.1% in 2024 and are expected to reach USD 62.7 billion through 2034. This approach allows manufacturers to offer competitive pricing by eliminating intermediary margins. Bulk purchase incentives and long-term agreements attract healthcare providers seeking cost efficiency, boosting the adoption of infusion pumps, IV kits, and associated disposables.

North America Home Infusion Therapy Market held a 44.2% share in 2024. The region's high prevalence of chronic illnesses such as cancer, diabetes, Crohn's disease, and immune deficiencies has driven strong demand for long-term IV therapies. The growing patient population in the U.S. and Canada is supporting steady growth in home infusion therapy services.

Prominent players in the Global Home Infusion Therapy Market include ICU Medical, Terumo, Fresenius Kabi, Moog, Mindray, B. Braun, Baxter, Nipro, JMS, Avanos (Halyard Health), Contec Medical Systems, Polymed, Erenler Medikal, AMSINO, and Becton Dickinson and Company. Companies in the Home Infusion Therapy Market employ several strategies to strengthen their presence and market position. They focus on continuous innovation, developing portable and user-friendly infusion pumps with advanced safety and remote monitoring features. Strategic partnerships with hospitals, clinics, and home healthcare providers expand distribution networks and enhance credibility. Geographic expansion into emerging markets allows access to new patient populations, while mergers and acquisitions help consolidate technology and product portfolios.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 Distribution channel trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing hospital acquired infections
      • 3.2.1.2 Rising prevalence of chronic diseases
      • 3.2.1.3 Advancements in technology
      • 3.2.1.4 Growing geriatric population
      • 3.2.1.5 Increasing preference towards at-home healthcare solutions
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Dearth of reimbursement
      • 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of intravenous immunoglobulin (IVIG) therapy
      • 3.2.3.2 Growing demand for personalized care
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Trends in home infusion therapy industry
  • 3.8 Pricing analysis, 2024
  • 3.9 Future prospects for home infusion therapy industry
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis
  • 3.13 Start-up scenario
  • 3.14 Consumer behaviour analysis
  • 3.15 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Infusion pumps
    • 5.2.1 Syringe
    • 5.2.2 Volumetric
    • 5.2.3 Ambulatory
    • 5.2.4 Insulin
    • 5.2.5 Other infusion pumps
  • 5.3 Needleless connectors
  • 5.4 Intravenous sets
  • 5.5 IV cannulas

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Anti-infective
  • 6.3 Enteral nutrition
  • 6.4 Specialty pharmaceuticals
  • 6.5 Parenteral nutrition
  • 6.6 Hydration therapy
  • 6.7 Chemotherapy
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Direct sales
  • 7.3 Indirect sales

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 AMSINO
  • 9.2 B. BRAUN
  • 9.3 Baxter
  • 9.4 Becton Dickinson and Company
  • 9.5 Contec Medical Systems
  • 9.6 ERENLER MEDIKAL
  • 9.7 FRESENIUS KABI
  • 9.8 Halyard Health (AVANOS)
  • 9.9 ICU Medical
  • 9.10 JMS
  • 9.11 Mindray
  • 9.12 Moog
  • 9.13 NIPRO
  • 9.14 POLYMED
  • 9.15 TERUMO